Skip to main content

MJFF Publications

1871 - 1880 of 7730 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • RESTRICTED
    Title: Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.022
    Citation Count: 8
  • RESTRICTED
    Title: L1CAM‐associated extracellular vesicles: A systematic review of nomenclature, sources, separation, and characterization
    Journal Name: Journal of Extracellular Biology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/jex2.35
    Citation Count: 44
  • RESTRICTED
    Title: Lessons from metabolic perturbations in lysosomal storage disorders for neurodegeneration
    Journal Name: Current Opinion in Systems Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.coisb.2021.100408
    Best OA location URL:
    Citation Count: 9
  • RESTRICTED
    Title: Llamanade: An open-source computational pipeline for robust nanobody humanization
    Journal Name: Structure
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.str.2021.11.006
    Citation Count: 24
  • RESTRICTED
    Title: Long-term adherence of human brain cells in vitro is enhanced by charged amine-based plasma polymer coatings
    Journal Name: Stem Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.stemcr.2022.01.013
    Citation Count: 12
  • RESTRICTED
    Title: LRRK2 and idiopathic Parkinson’s disease
    Journal Name: Trends in Neurosciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.tins.2021.12.002
    Citation Count: 59
  • RESTRICTED
    Title: Lysosomal dysfunction in neurodegeneration: emerging concepts and methods
    Journal Name: Trends in Neurosciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: elsevier-specific: oa user license, elsevier-specific: oa user license
    DOI - Digital Object Identifier: 10.1016/j.tins.2021.12.004
    Citation Count: 61
  • RESTRICTED
    Title: More of less: Novel multi-ome profiling of single human neurons
    Journal Name: Cell Genomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.xgen.2022.100110
    Citation Count: 0
  • RESTRICTED
    Title: Necessity and feasibility of remote tele-programming of deep brain stimulation systems in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.017
    Citation Count: 16
  • RESTRICTED
    Title: Polygenic burden of Parkinson's disease risk stratifies the prognosis of isolated rapid-eye-movement disorder: A preliminary observational study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.005
    Citation Count: 2
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.